Search details
1.
From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).
Oncologist
; 24(6): e318-e326, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30846513
2.
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial.
J Thorac Oncol
; 17(9): 1086-1097, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35659580
3.
Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach.
Oncologist
; 14(5): 497-510, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19423674
4.
Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.
Lung Cancer
; 133: 62-68, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31200830
5.
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.
J Clin Oncol
; 36(25): 2585-2592, 2018 09 01.
Article
in English
| MEDLINE | ID: mdl-30028656
6.
Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey.
Clin Lung Cancer
; 18(4): 381-387, 2017 07.
Article
in English
| MEDLINE | ID: mdl-27965013
7.
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.
J Clin Oncol
; 23(28): 6865-72, 2005 Oct 01.
Article
in English
| MEDLINE | ID: mdl-16192578
8.
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
J Natl Cancer Inst
; 95(5): 362-72, 2003 Mar 05.
Article
in English
| MEDLINE | ID: mdl-12618501
9.
Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience.
BMC Res Notes
; 5: 482, 2012 Sep 03.
Article
in English
| MEDLINE | ID: mdl-22943698
10.
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.
Lancet Oncol
; 8(6): 500-12, 2007 Jun.
Article
in English
| MEDLINE | ID: mdl-17513173
11.
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.
Lancet Oncol
; 6(9): 669-77, 2005 Sep.
Article
in English
| MEDLINE | ID: mdl-16129367
12.
The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
Stem Cells
; 21(1): 33-40, 2003.
Article
in English
| MEDLINE | ID: mdl-12529549
Results
1 -
12
de 12
1
Next >
>>